These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23580446)

  • 1. Pharmacological inhibition of platelet-tumor cell cross-talk prevents platelet-induced overexpression of cyclooxygenase-2 in HT29 human colon carcinoma cells.
    Dovizio M; Maier TJ; Alberti S; Di Francesco L; Marcantoni E; Münch G; John CM; Suess B; Sgambato A; Steinhilber D; Patrignani P
    Mol Pharmacol; 2013 Jul; 84(1):25-40. PubMed ID: 23580446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells.
    Guillem-Llobat P; Dovizio M; Bruno A; Ricciotti E; Cufino V; Sacco A; Grande R; Alberti S; Arena V; Cirillo M; Patrono C; FitzGerald GA; Steinhilber D; Sgambato A; Patrignani P
    Oncotarget; 2016 May; 7(22):32462-77. PubMed ID: 27074574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The COX-2 selective inhibitor-independent COX-2 effect on colon carcinoma cells is associated with the Delta1/Notch1 pathway.
    Zhang H; Ye Y; Bai Z; Wang S
    Dig Dis Sci; 2008 Aug; 53(8):2195-203. PubMed ID: 18320325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition.
    Chandler HL; Barden CA; Lu P; Kusewitt DF; Colitz CM
    Mol Vis; 2007 Apr; 13():677-91. PubMed ID: 17563718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiplatelet agent revacept prevents the increase of systemic thromboxane A
    Alberti S; Zhang Q; D'Agostino I; Bruno A; Tacconelli S; Contursi A; Guarnieri S; Dovizio M; Falcone L; Ballerini P; Münch G; Yu Y; Patrignani P
    Sci Rep; 2020 Dec; 10(1):21420. PubMed ID: 33293599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet glycoprotein VI promotes metastasis through interaction with cancer cell-derived galectin-3.
    Mammadova-Bach E; Gil-Pulido J; Sarukhanyan E; Burkard P; Shityakov S; Schonhart C; Stegner D; Remer K; Nurden P; Nurden AT; Dandekar T; Nehez L; Dank M; Braun A; Mezzano D; Abrams SI; Nieswandt B
    Blood; 2020 Apr; 135(14):1146-1160. PubMed ID: 32040544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caveolin-1-mediated suppression of cyclooxygenase-2 via a beta-catenin-Tcf/Lef-dependent transcriptional mechanism reduced prostaglandin E2 production and survivin expression.
    Rodriguez DA; Tapia JC; Fernandez JG; Torres VA; Muñoz N; Galleguillos D; Leyton L; Quest AF
    Mol Biol Cell; 2009 Apr; 20(8):2297-310. PubMed ID: 19244345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GPVI-Fc fusion protein Revacept improves cerebral infarct volume and functional outcome in stroke.
    Goebel S; Li Z; Vogelmann J; Holthoff HP; Degen H; Hermann DM; Gawaz M; Ungerer M; Münch G
    PLoS One; 2013; 8(7):e66960. PubMed ID: 23935828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine increases colon cancer cell migration and invasion through epithelial to mesenchymal transition (EMT): COX-2 involvement.
    Dinicola S; Masiello MG; Proietti S; Coluccia P; Fabrizi G; Catizone A; Ricci G; de Toma G; Bizzarri M; Cucina A
    J Cell Physiol; 2018 Jun; 233(6):4935-4948. PubMed ID: 29215713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells.
    Tammali R; Saxena A; Srivastava SK; Ramana KV
    J Biol Chem; 2011 Jul; 286(27):24089-100. PubMed ID: 21576240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNFα-activated stromal COX-2 signalling promotes proliferative and invasive potential of colon cancer epithelial cells.
    Zhu M; Zhu Y; Lance P
    Cell Prolif; 2013 Aug; 46(4):374-81. PubMed ID: 23869759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells.
    Bocca C; Bozzo F; Cannito S; Parola M; Miglietta A
    Mol Carcinog; 2012 Oct; 51(10):783-95. PubMed ID: 21882253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteers.
    Graff J; Skarke C; Klinkhardt U; Watzer B; Harder S; Seyberth H; Geisslinger G; Nüsing RM
    J Thromb Haemost; 2007 Dec; 5(12):2376-85. PubMed ID: 17916229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin inhibits colon cancer cell growth through cyclooxygenase-2 downregulation.
    Colucci R; Blandizzi C; Ghisu N; Florio T; Del Tacca M
    Br J Pharmacol; 2008 Sep; 155(2):198-209. PubMed ID: 18587421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rofecoxib has different effects on chemokine production in colorectal cancer cells and tumor immune splenocytes.
    Walmesley AJ; Zweiri J; Christmas SE; Watson AJ
    J Immunother; 2007 Sep; 30(6):614-23. PubMed ID: 17667525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β1 downregulates COX-2 expression leading to decrease of PGE2 production in human lung cancer A549 cells, which is involved in fibrotic response to TGF-β1.
    Takai E; Tsukimoto M; Kojima S
    PLoS One; 2013; 8(10):e76346. PubMed ID: 24098479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of COX-2 by RNAi modulates epithelial-mesenchymal transition in breast cancer cells partially dependent on the PGE2 cascade.
    Cao J; Yang X; Li WT; Zhao CL; Lv SJ
    Asian Pac J Cancer Prev; 2014; 15(22):9967-72. PubMed ID: 25520137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The calcium-sensing receptor suppresses epithelial-to-mesenchymal transition and stem cell- like phenotype in the colon.
    Aggarwal A; Prinz-Wohlgenannt M; Gröschel C; Tennakoon S; Meshcheryakova A; Chang W; Brown EM; Mechtcheriakova D; Kállay E
    Mol Cancer; 2015 Mar; 14():61. PubMed ID: 25879211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel insights into the regulation of cyclooxygenase-2 expression by platelet-cancer cell cross-talk.
    Dovizio M; Alberti S; Sacco A; Guillem-Llobat P; Schiavone S; Maier TJ; Steinhilber D; Patrignani P
    Biochem Soc Trans; 2015 Aug; 43(4):707-14. PubMed ID: 26551717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibition.
    Zhang Y; Hoda MN; Zheng X; Li W; Luo P; Maddipati KR; Seki T; Ergul A; Wang MH
    Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(6):R693-703. PubMed ID: 24990856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.